Patents by Inventor Charles Emrich

Charles Emrich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240209306
    Abstract: Methods and systems for iteratively improving culture condition for at least one culture output in a culture process. The methods comprise: a) providing a continuous culture of cells in a bioreactor, wherein the cells are cultured under culture conditions that comprise a set of culture parameters. and wherein the culture of cells produces at least one culture output at a first measure: b) while maintaining the cells in continuous culture, iteratively testing different culture conditions by: (i) selecting a new culture condition comprising a new set of culture parameters predicted to improve the measure of the culture output: (ii) perturbing the cells with the new culture conditions: and (iii) determining a new measure of the culture output: wherein testing is iterated to produce a plurality of improvements in the measure of culture output. The iterative process can be performed by an automated artificial intelligence.
    Type: Application
    Filed: December 21, 2022
    Publication date: June 27, 2024
    Inventors: Shannon HALL, Ouwei WANG, Brian LEE, Charles EMRICH
  • Publication number: 20190161786
    Abstract: Provided herein are systems and components thereof for improving protease activity. The systems make use of an emulsion for in vitro compartmentalization of a library of synthetic compounds, each compound having a gene linked to a protease substrate and selectable marker. Expressed enzymes with greater protease activity will preferentially hydrolyze the protease substrate, whereas enzymes with less protease activity will leave the substrate intact. Removal of the non-hydrolyzed compounds provides an enriched gene library encoding for more active protease variants. Also described are synthetic compounds and emulsions which can be used in the methods.
    Type: Application
    Filed: April 7, 2017
    Publication date: May 30, 2019
    Applicant: NOVOZYMES A/S
    Inventors: Robert Blazej, Nicholas Toriello, Charles Emrich
  • Publication number: 20190078097
    Abstract: The present invention relates to polynucleotide constructs for in vitro and in vivo transcription/translation of genes of interest or variants of a gene of interest as well as microorganism host cells comprising such constructs and methods for producing a polypeptide of interest in such microorganism host cells.
    Type: Application
    Filed: October 28, 2016
    Publication date: March 14, 2019
    Applicant: Novozymes A/S
    Inventors: Charles Emrich, Jesper Vind
  • Publication number: 20180355404
    Abstract: Provided herein are methods and means for enhancing lipase activity. The system makes use of an emulsion for in vitro compartmentalization of a library of synthetic compounds which have a polynucleotide linked to a lipase substrate (e.g., a triglyceride). Expressed polypeptides having greater lipase activity will preferentially hydrolyze the substrate from the linked polynucleotide. Genes encoding polypeptides having less lipase activity will remain linked to the substrate and may be removed to enrich the library for more active variants. Also described are synthetic compounds and emulsions which can be used in the methods.
    Type: Application
    Filed: April 7, 2016
    Publication date: December 13, 2018
    Inventors: Robert Blazej, Nicholas Toriello, Charles Emrich, Allan Svendsen, Jesper Brask, Anne Olsen, Kathleen Hirano, Amy Twite
  • Publication number: 20180073017
    Abstract: Provided herein are methods and means for enhancing enzymatic activity. The system makes use of an emulsion for in vitro compartmentalization of a library of synthetic compounds which have a gene and a marked enzymatic substrate both directly linked to a solid phase. Expressed enzymes with greater activity will preferentially release the selectable marker from the solid phase, whereas enzymes with less activity will leave the markers intact. Removal of the marked compounds provides an enriched gene library encoding for more active variants. Also described are synthetic compounds and emulsions which can be used in the methods.
    Type: Application
    Filed: April 7, 2016
    Publication date: March 15, 2018
    Applicant: NOVOZYMES A/S
    Inventors: Robert Blazej, Nicholas Toriello, Charles Emrich, Allan Svendsen
  • Publication number: 20170369860
    Abstract: The present invention relates to endoglucanase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, expression vectors, and recombinant host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: January 6, 2016
    Publication date: December 28, 2017
    Applicant: Novozymes A/S
    Inventors: Robert Blazej, Charles Emrich, Nicholas Toriello, Hanshu Ding, David Osborn, Aubrey Jones
  • Publication number: 20150218553
    Abstract: The present invention provides methods based on screening expressed polynucleotide libraries for soluble proteins.
    Type: Application
    Filed: September 20, 2013
    Publication date: August 6, 2015
    Applicant: Novozymes A/S
    Inventors: Robert Blazej, Nicholas Toriello, Charles Emrich
  • Patent number: 9080162
    Abstract: This invention provides novel variant cellulolytic enzymes having improved activity and/or stability. In certain embodiments the variant cellulotyic enzymes comprise a glycoside hydrolase with or comprising a substitution at one or more positions corresponding to one or more of residues F64, A226, and/or E246 in Thermobifida fusca Cel9A enzyme. In certain embodiments the glycoside hydrolase is a variant of a family 9 glycoside hydrolase. In certain embodiments the glycoside hydrolase is a variant of a theme B family 9 glycoside hydrolase.
    Type: Grant
    Filed: April 11, 2012
    Date of Patent: July 14, 2015
    Assignee: Novozymes, A/S
    Inventors: Robert Blazej, Nicholas Toriello, Charles Emrich, Richard N. Cohen, Nitzan Koppel
  • Publication number: 20140113335
    Abstract: This invention provides novel variant cellulolytic enzymes having improved activity and/or stability. In certain embodiments the variant cellulotyic enzymes comprise a glycoside hydrolase with or comprising a substitution at one or more positions corresponding to one or more of residues F64, A226, and/or E246 in Thermobifida fusca Cel9A enzyme. In certain embodiments the glycoside hydrolase is a variant of a family 9 glycoside hydrolase. In certain embodiments the glycoside hydrolase is a variant of a theme B family 9 glycoside hydrolase.
    Type: Application
    Filed: April 11, 2012
    Publication date: April 24, 2014
    Applicant: Novozymes A/S
    Inventors: Robert Blazej, Nicholas Toriello, Charles Emrich, Richard N. Cohen, Nitzan Koppel
  • Publication number: 20050230254
    Abstract: An electrochemical detector including side channels associated with a separation channel of a sample component separation apparatus is provided. The side channels of the detector, in one configuration, provide a sheath-flow for an analyte exiting the separation channel which directs the analyte to the electrically developed electrochemical detector.
    Type: Application
    Filed: April 14, 2005
    Publication date: October 20, 2005
    Applicant: The Regents of the University of California
    Inventors: Richard Mathies, Charles Emrich, Pankaj Singhal, Peter Ertl